Table 2.
Impact of FNC Dosing on the Behaviour of Mice
| Groups | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameters | C | F-1 | F-10 | F-25 | Parameters | C | F-1 | F-10 | F-25 | ||
| 1 | General Physique | N (1) | N (2) | N (1) | N | 15 | Urination | N (2) | N (3) | N (3) | N |
| 2 | Skin/Fur Color | N | N | N (2) | N | 16. | Fecation of mice | GB (1) | GB (3) | GB (2) | GB |
| 3 | Fur appearance | A/NT/S | A/NT/S | A/NT/S | A/NT/S | 17 | Mice movements | N (3) | N (2) | N (4) | A (8)* |
| 4 | Skin allergy | No | No | No | No | 18 | Exploratory activity | N (1) | N (4)* | A (7)* | A (5)* |
| 5 | Eyes Abnormality | No | No | No | No | 19. | Body cleanliness | G (3) | G (4) | G (1) | G (2) |
| 6 | Eyes Color | P | P | P | P | 20 | Abnormal Behavior | No (1) | Y (4)* | No (1) | Y (5)* |
| 7 | (Pink/White) | ||||||||||
| 8 | Eyes Bulge | N | N | N | N | 21 | Sleep Pattern | N (2) | N (1) | N (2) | N (3) |
| 22 | Sleep | N (1) | N (2) | N (3)* | A (6)* | ||||||
| Playing pattern | N (1) | A (5)* | A (4)* | A (4)* | 23 | Lethargy | No (3) | No (3) | No (2) | No (2) | |
| 9 | Cuddling | N (2) | A (8)* | A (4)* | A (5)* | 24 | Drowsiness | N (3) | N (4) | N (4) | N (3) |
| 10 | Aggressive behaviour | No (1) | No (1) | Y (3)* | Y (4)* | 25 | Sedation | No (2) | No (3) | No (2) | No (2) |
| 26 | Tremors | No | No | No | No | ||||||
| 11 | Visible respiration problem | No | No | No | No | 27 | Convulsion | No | No | No | No |
| 12 | Rate of respiration | N | N | N | N | 28 | Salivation | No | No | No (1) | No (1) |
| 13 | Body temperature | N | N | N (1) | N (2) | 29 | Coma | No | No | No | No |
| 14 | Diarrhoea | No | No | No (1) | No (2) | 30 | Death/Live | L | L | L | L |
N, Normal; A, Altered; No, Not present; Y, Yes; A/NT/S, Albino white/non-tangled/straight; G, good; GB, greenish black; P, Pink; The bracket digits indicate days of altered activity. Data of altered activities days were used to calculate significance data. R2 (Repeated two times). The data were analysed using two-way ANOVA followed by Bonferroni post-test. Significant at p<0.05%.